STOCK TITAN

MariMed Announces Fourth Quarter and Full Year 2021 Earnings Date

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

MariMed, Inc. (OTCQX: MRMD) will release its fourth quarter and full year 2021 financial results on March 16, 2022, after market close. A conference call to discuss these results is scheduled for March 17, 2022, at 8:00 a.m. ET. The call will be accessible via MariMed's Investor Relations website, where a playback will be available for 30 days. MariMed is recognized as a leading multi-state cannabis operator, focusing on high-quality products and consistent growth through its management team and proprietary formulations.

Positive
  • Upcoming financial results could show growth potential for investors.
  • Strong product brands like Betty's Eddies™ and Nature’s Heritage™ are well-established in the market.
Negative
  • None.

NORWOOD, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its fourth quarter and full year 2021 financial results for the period ending December 31, 2021 on March 16, 2022 after market close. Management will host a conference call on March 17, 2022 at 8:00 a.m. ET to discuss the results.

A webcast will be available and can be accessed via MariMed’s Investor Relations website at www.ir.marimedinc.com. To listen to the live call, please visit the website at least 15 minutes early to register, download and install any necessary audio software. A playback of the call will be archived on MariMed’s website for approximately 30 days.

About MariMed
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies™, Nature’s Heritage™, Bubby’s Baked™, k FUSION™, and Kalm FUSION™. For additional information, visit www.marimedinc.com.

Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com

Media Contact:
Trailblaze PR
Email: marimed@trailblaze.co

Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com


FAQ

When will MariMed report its fourth quarter 2021 earnings?

MariMed will report its fourth quarter and full year 2021 financial results on March 16, 2022.

What time is the MariMed conference call for discussing financial results?

The conference call is scheduled for March 17, 2022, at 8:00 a.m. ET.

Where can I find the MariMed conference call audio?

The audio for the conference call will be available on MariMed's Investor Relations website.

What is the stock symbol for MariMed?

The stock symbol for MariMed is MRMD.

MARIMED INC

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Stock Data

55.29M
280.32M
14.03%
0.3%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Norwood